Performance of the 2021 Race-Free CKD-EPI Creatinine- and Cystatin C-Based Estimated GFR Equations Among Kidney Transplant Recipients.

African American CKD staging CKD-EPI GFR (Glomerular filtration rate) allograft function chronic kidney disease (CKD) eGFR (estimated glomerular filtration rate) end-stage renal disease (ESRD) kidney transplant laboratory testing measurement accuracy race race and ethnicity racial disparities renal function serum creatinine serum cystatin C transplant

Journal

American journal of kidney diseases : the official journal of the National Kidney Foundation
ISSN: 1523-6838
Titre abrégé: Am J Kidney Dis
Pays: United States
ID NLM: 8110075

Informations de publication

Date de publication:
10 2022
Historique:
received: 15 11 2021
accepted: 11 03 2022
pubmed: 20 5 2022
medline: 28 9 2022
entrez: 19 5 2022
Statut: ppublish

Résumé

Race-free estimated glomerular filtration rate (eGFR) equations incorporating creatinine with and without cystatin C were recently developed and recommended for routine use. However, the performance of these equations among kidney transplant recipients (KTRs) remains unknown. Cross-sectional study to validate the 2021 race-free Chronic Kidney Disease (CKD) Epidemiology Collaboration (CKD-EPI) eGFR equation based on creatinine alone (eGFR KTRs in stable condition (N = 415) from Canada and New Zealand with same-day measurements of creatinine, cystatin C, and glomerular filtration rate (GFR) using radiolabeled diethylenetriaminepentaacetic acid. The 2009 CKD-EPI eGFR Bias, precision, accuracy, and correct classification by CKD stage. Bias was defined as the difference between estimated and measured GFR. Precision was represented by the interquartile range. Accuracy was defined as the percentages of participants with eGFRs within 10%/20%/30% (P 87% of patients studied were White, 3% Black, and 10% other races. Mean measured GFR was 53 ± 19 (SD) mL/min/1.73 m Moderate sample size, few patients had a GFR <30 mL/min/1.73 m Among KTRs, the 2021 race-free CKD-EPI eGFR equations perform similarly to the previous CKD-EPI equations that included race correction terms. No significant difference in performance was observed between the 2021 CKD-EPI eGFR

Identifiants

pubmed: 35588905
pii: S0272-6386(22)00643-6
doi: 10.1053/j.ajkd.2022.03.014
pii:
doi:

Substances chimiques

Cystatin C 0
Creatinine AYI8EX34EU

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

462-472.e1

Subventions

Organisme : CIHR
Pays : Canada

Commentaires et corrections

Type : CommentIn

Informations de copyright

Copyright © 2022 National Kidney Foundation, Inc. Published by Elsevier Inc. All rights reserved.

Auteurs

Gregory L Hundemer (GL)

Department of Medicine, Division of Nephrology, and Ottawa Hospital Research Institute, University of Ottawa, Ottawa.

Christine A White (CA)

Division of Nephrology, Department of Medicine, Kingston, Ontario. Electronic address: cw38@queensu.ca.

Patrick A Norman (PA)

Department of Public Health Sciences, Kingston, Ontario; Queen's University, Kingston General Health Research Institute, Kingston, Ontario.

Greg A Knoll (GA)

Department of Medicine, Division of Nephrology, and Ottawa Hospital Research Institute, University of Ottawa, Ottawa.

Navdeep Tangri (N)

Division of Nephrology, Department of Medicine, University of Manitoba, Winnipeg, Manitoba, Canada.

Manish M Sood (MM)

Department of Medicine, Division of Nephrology, and Ottawa Hospital Research Institute, University of Ottawa, Ottawa.

Swapnil Hiremath (S)

Department of Medicine, Division of Nephrology, and Ottawa Hospital Research Institute, University of Ottawa, Ottawa.

Kevin D Burns (KD)

Department of Medicine, Division of Nephrology, and Ottawa Hospital Research Institute, University of Ottawa, Ottawa.

Christopher McCudden (C)

Department of Pathology and Laboratory Medicine, University of Ottawa, Ottawa.

Ayub Akbari (A)

Department of Medicine, Division of Nephrology, and Ottawa Hospital Research Institute, University of Ottawa, Ottawa.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH